Abstract
Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
The Natural Products Journal
Title:Phytochemistry and Pharmacological Update on Tetraterpenoids
Volume: 11 Issue: 5
Author(s): Sapna Kumari*, Anju Goyal and Madhukar Garg
Affiliation:
- Chitkara College of Pharmacy, Chitkara University, Punjab,India
Keywords: Carotenoids, lycopene, carotene, xanthophylls, nano-formulations, tetraterpenoids.
Abstract: Tetraterpenoids comprise of a large family of C 40 polyene, obtained from plants, fungi and bacteria. Their colouring properties have been employed to use as a natural colorant in the pharmaceutical industries. These exist as an attractive target of research because of their easy availability and plentiful health benefits in cardiovascular diseases, cancer, age related degenerative diseases, macular degeneration, antiatherosclerotic, anti-inflammatory, immunomodulatory properties and in HIV infection, probably due to their antioxidant properties. Formulating carotenoids in a particular dosage form is a big challenge as they possess some limitations like chemical unstability, poor bioavailability, less solubility and quick release. Due to this, numerous nanoencapsulation techniques have been developed till now to maintain their original properties. This review will highlight the phytochemical and pharmacological update on tetraterpenoids and their formulations.
Export Options
About this article
Cite this article as:
Kumari Sapna *, Goyal Anju and Garg Madhukar , Phytochemistry and Pharmacological Update on Tetraterpenoids, The Natural Products Journal 2021; 11 (5) . https://dx.doi.org/10.2174/2210315510999200806154609
DOI https://dx.doi.org/10.2174/2210315510999200806154609 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design Cardiovascular Disease in Juvenile Idiopathic Arthritis
Current Vascular Pharmacology Inflammation: A Link Between Hypertension and Atherosclerosis
Current Hypertension Reviews Uric Acid Metabolism in Pre-hypertension and the Metabolic Syndrome
Current Vascular Pharmacology Left Ventricular Hypertrophy in ADPKD: Changing Demographics
Current Hypertension Reviews Air Pollution Exposure and Blood Pressure: An Updated Review of the Literature
Current Pharmaceutical Design Management of the Metabolic Syndrome as a Strategy for Preventing the Macrovascular Complications of Type 2 Diabetes: Controversial Issues
Current Diabetes Reviews Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Current Pharmaceutical Design Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation® Program: A Research Review Update
Current Hypertension Reviews Dopamine and Vascular Dynamics Control: Present Status and Future Perspectives
Current Neurovascular Research High Glucose-Mediated Imbalance of Nitric Oxide Synthase and Dimethylarginine Dimethylaminohydrolase Expression in Endothelial Cells
Current Neurovascular Research Inflammation Markers in Essential Hypertension
Medicinal Chemistry Novel Concepts in the Pathogenesis and Management of Pediatric Hypertension
Current Pediatric Reviews Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
Current Medicinal Chemistry Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine The Concomitance of Hypertension and Diabetes Exacerbating Retinopathy: The Role of Inflammation and Oxidative Stress.
Current Clinical Pharmacology Hypertensive Heart Disease and the Role of Aldosterone Antagonists
Current Hypertension Reviews Genomics and Pharmacogenomics of Salt-sensitive Hypertension
Current Hypertension Reviews Family History and Preclinical Atherosclerosis
Current Hypertension Reviews Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology